Stefano Vavassori1, Janet Chou2, Laura Eva Faletti3, Veronika Haunerdinger4, Lennart Opitz5, Pascal Joset6, Christopher J Fraser7, Seraina Prader1, Xianfei Gao8, Luise A Schuch8, Matias Wagner9, Julia Hoefele9, Maria Elena Maccari3, Ying Zhu10, George Elakis10, Michael T Gabbett11, Maria Forstner8, Heymut Omran12, Thomas Kaiser12, Christina Kessler12, Heike Olbrich12, Patrick Frosk13, Abduarahman Almutairi14, Craig D Platt2, Megan Elkins2, Sabrina Weeks2, Tamar Rubin15, Raquel Planas1, Tommaso Marchetti1, Danil Koovely1, Verena Klämbt16, Neveen A Soliman17, Sandra von Hardenberg18, Christian Klemann19, Ulrich Baumann19, Dominic Lenz20, Andreas Klein-Franke21, Martin Schwemmle22, Michael Huber23, Ekkehard Sturm24, Steffen Hartleif24, Karsten Häffner25, Charlotte Gimpel25, Barbara Brotschi26, Guido Laube27, Tayfun Güngör4, Michael F Buckley10, Raimund Kottke28, Christian Staufner20, Friedhelm Hildebrandt16, Simone Reu-Hofer29, Solange Moll30, Achim Weber31, Hundeep Kaur32, Stephan Ehl3, Sebastian Hiller32, Raif Geha33, Tony Roscioli34, Matthias Griese8, Jana Pachlopnik Schmid35. 1. Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. 2. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass. 3. Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 4. Division of Stem Cell Transplantation and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. 5. Functional Genomics Center Zürich, University of Zurich, Zurich, Switzerland. 6. Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland. 7. Queensland Children's Hospital, South Brisbane, Australia. 8. Division of Pediatric Pneumology, Dr. von Hauner Children's Hospital, University Hospital Munich, German Center for Lung Research (DZL), Munich, Germany. 9. Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany. 10. New South Wales Health Pathology Genomics, Prince of Wales Hospital, Sydney, Australia. 11. Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia. 12. Clinic for General Pediatrics, University Hospital Münster, Münster, Germany. 13. Division of Clinical Immunology and Allergy, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada. 14. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass; Department of Pediatrics, Security Forces Hospital, Riyadh, Saudi Arabia. 15. Division of Pediatric Clinical Immunology and Allergy, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada. 16. Division of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, Mass. 17. Department of Pediatrics, Center of Pediatric Nephrology and Transplantation, Cairo University, Cairo, Egypt. 18. Department of Human Genetics, Hannover Medical School, Hannover, Germany. 19. Department of Paediatric Pulmonology, Allergy and Neonatology, Hannover Medical School, Hannover, Germany. 20. Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany. 21. Division of Pediatric Hematology and Oncology, Cantonal Hospital Aarau, Aarau, Switzerland. 22. Institute of Virology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 23. Institute of Medical Virology, University of Zurich, Zurich, Switzerland. 24. Division of Pediatric Gastroenterology and Hepatology, University Hospital Tübingen, Tübingen, Germany. 25. Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 26. Department of Pediatric and Neonatal Intensive Care, University Children's Hospital Zurich, Zurich, Switzerland. 27. Division of Nephrology, University Children's Hospital Zurich, Zurich, Switzerland. 28. Division of Neuroradiology, Department of Diagnostic Imaging and Intervention, University Children's Hospital Zurich, Zurich, Switzerland. 29. Institute of Pathology, University of Würzburg, Würzburg, Germany. 30. Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland. 31. Department of Pathology and Molecular Pathology, and Institute of Molecular Cancer Research, University Hospital and University of Zurich, Zurich, Switzerland. 32. Biozentrum, University of Basel, Basel, Switzerland. 33. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass. Electronic address: raif.geha@childrens.harvard.edu. 34. New South Wales Health Pathology Genomics, Prince of Wales Hospital, Sydney, Australia; Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, Sydney, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia; Neuroscience Research Australia, University of New South Wales, Sydney, Australia. 35. Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland; Pediatric Immunology, University of Zurich, Zurich, Switzerland. Electronic address: jana.pachlopnik@kispi.uzh.ch.
Abstract
BACKGROUND: Recognition of viral nucleic acids is one of the primary triggers for a type I interferon-mediated antiviral immune response. Inborn errors of type I interferon immunity can be associated with increased inflammation and/or increased susceptibility to viral infections as a result of dysbalanced interferon production. NFX1-type zinc finger-containing 1 (ZNFX1) is an interferon-stimulated double-stranded RNA sensor that restricts the replication of RNA viruses in mice. The role of ZNFX1 in the human immune response is not known. OBJECTIVE: We studied 15 patients from 8 families with an autosomal recessive immunodeficiency characterized by severe infections by both RNA and DNA viruses and virally triggered inflammatory episodes with hemophagocytic lymphohistiocytosis-like disease, early-onset seizures, and renal and lung disease. METHODS: Whole exome sequencing was performed on 13 patients from 8 families. We investigated the transcriptome, posttranscriptional regulation of interferon-stimulated genes (ISGs) and predisposition to viral infections in primary cells from patients and controls stimulated with synthetic double-stranded nucleic acids. RESULTS: Deleterious homozygous and compound heterozygous ZNFX1 variants were identified in all 13 patients. Stimulation of patient-derived primary cells with synthetic double-stranded nucleic acids was associated with a deregulated pattern of expression of ISGs and alterations in the half-life of the mRNA of ISGs and also associated with poorer clearance of viral infections by monocytes. CONCLUSION: ZNFX1 is an important regulator of the response to double-stranded nucleic acids stimuli following viral infections. ZNFX1 deficiency predisposes to severe viral infections and a multisystem inflammatory disease.
BACKGROUND: Recognition of viral nucleic acids is one of the primary triggers for a type I interferon-mediated antiviral immune response. Inborn errors of type I interferon immunity can be associated with increased inflammation and/or increased susceptibility to viral infections as a result of dysbalanced interferon production. NFX1-type zinc finger-containing 1 (ZNFX1) is an interferon-stimulated double-stranded RNA sensor that restricts the replication of RNA viruses in mice. The role of ZNFX1 in the human immune response is not known. OBJECTIVE: We studied 15 patients from 8 families with an autosomal recessive immunodeficiency characterized by severe infections by both RNA and DNA viruses and virally triggered inflammatory episodes with hemophagocytic lymphohistiocytosis-like disease, early-onset seizures, and renal and lung disease. METHODS: Whole exome sequencing was performed on 13 patients from 8 families. We investigated the transcriptome, posttranscriptional regulation of interferon-stimulated genes (ISGs) and predisposition to viral infections in primary cells from patients and controls stimulated with synthetic double-stranded nucleic acids. RESULTS: Deleterious homozygous and compound heterozygous ZNFX1 variants were identified in all 13 patients. Stimulation of patient-derived primary cells with synthetic double-stranded nucleic acids was associated with a deregulated pattern of expression of ISGs and alterations in the half-life of the mRNA of ISGs and also associated with poorer clearance of viral infections by monocytes. CONCLUSION: ZNFX1 is an important regulator of the response to double-stranded nucleic acids stimuli following viral infections. ZNFX1 deficiency predisposes to severe viral infections and a multisystem inflammatory disease.
Authors: Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka Journal: Pediatr Blood Cancer Date: 2007-02 Impact factor: 3.167
Authors: Johannes Schwerk; Frank W Soveg; Andrew P Ryan; Kerri R Thomas; Lauren D Hatfield; Snehal Ozarkar; Adriana Forero; Alison M Kell; Justin A Roby; Lomon So; Jennifer L Hyde; Michael Gale; Matthew D Daugherty; Ram Savan Journal: Nat Immunol Date: 2019-11-18 Impact factor: 25.606
Authors: Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky Journal: Nat Genet Date: 2014-09-14 Impact factor: 38.330
Authors: Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts Journal: J Clin Immunol Date: 2022-06-24 Impact factor: 8.542
Authors: Abhilash Kannan; Maarit Suomalainen; Romain Volle; Michael Bauer; Marco Amsler; Hung V Trinh; Stefano Vavassori; Jana Pachlopnik Schmid; Guilherme Vilhena; Alberto Marín-González; Ruben Perez; Andrea Franceschini; Christian von Mering; Silvio Hemmi; Urs F Greber Journal: Viruses Date: 2022-06-28 Impact factor: 5.818